SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: betty moyers who wrote (18753)2/13/1999 9:58:00 AM
From: Mkilloran  Read Replies (1) | Respond to of 23519
 
betty...it's not a question of skipping the April conf call...
I believe that by the July conf call we will be seeing the results of sales in Europe, as well as other established countries selling Muse..

I also think we will have a usa partner inplace before July (but may be after April) and will also have some positive results from the partners efforts.

For those that are buying in the $2-3 range I think that they will be rewarded with nice gains by the July conf call.



To: betty moyers who wrote (18753)2/14/1999 12:34:00 AM
From: Mkilloran  Read Replies (1) | Respond to of 23519
 
Betty...well our first insider has been spotted bought 42,750 shares

Neil Gesundheit exercised an option to buy 42,750 shares of vivus at $1.13 per share.....

Let's see who's next to report ........